Arrakis Therapeutics
Arrakis is developing RNA-targeted small molecule (rSM) therapies to millions of patients.
4
Funding Rounds
$226.0m
Money raised
Funding
Funding series
Funding Series Analysis
The company Arrakis Therapeutics has raised a total of $113m in funding over 4 rounds.
Key Insights:
- Arrakis Therapeutics Funding Round 2019: $75m
- Arrakis Therapeutics Series A round, February 2017: $38m
- Arrakis Therapeutics funding round, April 2019: $75m
- Arrakis Therapeutics funding round, February 2017: $38m
Arrakis Therapeutics Funding Round 2019
$75m
Arrakis Therapeutics Series A round, February 2017
$38m
Arrakis Therapeutics funding round, April 2019
$75m
Arrakis Therapeutics funding round, February 2017
$38m
Industries
Arrakis Therapeutics is active in the following industries:
- RNA-based and RNA-targeted therapeutics
- Biotechnology
- Healthcare
- Synthetic chemistry
- Pharmaceutical industry
- Drug development
- Engineering
- Technology
- Biology
- Biomedical engineering
- Therapeutics
- Medicine